Synthetic Biologics

Neglected dying tropical Syngonum Neon Robusta house plant in white flower pot on pink background
Biotech

George Church spinout restructures, considers strategic options

Big-shot academic origin, a star roster of investors and the proximity of a financing round render GRObio’s slip into uncertainty puzzling.
Angus Liu Mar 13, 2025 2:00pm
ax splitting wood

Biotechs cut pipeline prospects to focus on priority programs

Aug 11, 2022 9:43am
stop sign knerri61Pixabay

Synthetic Biologics cans phase 2 IBS trial deemed likely to fail

Oct 2, 2020 10:25am
FDA

Synthetic Biologics loses breakthrough status

Apr 23, 2018 9:00am
Wall Street

Tiny Synthorx raises $10M for synthetic amino acid trials

Jul 20, 2016 4:02am